Ralph Madeb
Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Urinary Bladder Neoplasms | 10 | 2001 | 44 |
Why?
| Prostatectomy | 10 | 2003 | 29 |
Why?
| Robotics | 8 | 2005 | 21 |
Why?
| Hematuria | 4 | 2006 | 20 |
Why?
| Laparoscopy | 6 | 2003 | 52 |
Why?
| Prostatic Neoplasms | 6 | 2000 | 120 |
Why?
| Mass Screening | 3 | 2006 | 125 |
Why?
| Chemotherapy, Adjuvant | 2 | 2006 | 55 |
Why?
| Humans | 45 | 2000 | 1856 |
Why?
| Male | 32 | 2000 | 1553 |
Why?
| Nephrectomy | 3 | 2001 | 36 |
Why?
| Reagent Strips | 1 | 2007 | 6 |
Why?
| Penile Erection | 1 | 2007 | 10 |
Why?
| Middle Aged | 20 | 2000 | 1161 |
Why?
| Priapism | 1 | 2007 | 6 |
Why?
| Internship and Residency | 1 | 2011 | 175 |
Why?
| Urinary Bladder Diseases | 2 | 2006 | 17 |
Why?
| Hydronephrosis | 2 | 2001 | 22 |
Why?
| Penile Neoplasms | 1 | 2007 | 12 |
Why?
| Urachal Cyst | 1 | 2006 | 6 |
Why?
| Urachus | 1 | 2006 | 6 |
Why?
| Cystectomy | 1 | 2006 | 9 |
Why?
| Iodophors | 1 | 2006 | 2 |
Why?
| Sclerotherapy | 1 | 2006 | 6 |
Why?
| Polycythemia | 1 | 2006 | 10 |
Why?
| Kidney Diseases, Cystic | 1 | 2006 | 9 |
Why?
| Povidone-Iodine | 1 | 2006 | 9 |
Why?
| Paraffin | 1 | 2006 | 7 |
Why?
| Kidney Pelvis | 1 | 2006 | 14 |
Why?
| Granuloma, Foreign-Body | 1 | 2006 | 5 |
Why?
| Ureteral Obstruction | 1 | 2006 | 21 |
Why?
| Antineoplastic Agents | 2 | 2006 | 190 |
Why?
| Physician's Practice Patterns | 1 | 2009 | 149 |
Why?
| Lymphoma, B-Cell | 1 | 2007 | 33 |
Why?
| Tuberculosis, Male Genital | 1 | 2005 | 2 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 38 |
Why?
| Epididymis | 1 | 2005 | 12 |
Why?
| Testicular Diseases | 1 | 2005 | 16 |
Why?
| Urologic Surgical Procedures | 1 | 2004 | 12 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2005 | 58 |
Why?
| Herpes Genitalis | 2 | 2000 | 9 |
Why?
| Urethritis | 2 | 2000 | 9 |
Why?
| Postoperative Complications | 3 | 2001 | 305 |
Why?
| Agranulocytosis | 1 | 2002 | 9 |
Why?
| Schizophrenia, Paranoid | 1 | 2002 | 5 |
Why?
| Serotonin Antagonists | 1 | 2002 | 9 |
Why?
| Insulin | 1 | 2005 | 129 |
Why?
| Clozapine | 1 | 2002 | 17 |
Why?
| Valproic Acid | 1 | 2002 | 26 |
Why?
| Aged | 15 | 2000 | 988 |
Why?
| Anticonvulsants | 1 | 2002 | 61 |
Why?
| Ureterocele | 1 | 2000 | 4 |
Why?
| Ultrasonography, Doppler, Color | 1 | 2000 | 27 |
Why?
| Time Factors | 4 | 2003 | 896 |
Why?
| Adult | 14 | 2000 | 1317 |
Why?
| Follow-Up Studies | 4 | 2000 | 553 |
Why?
| Recovery of Function | 2 | 2007 | 91 |
Why?
| Diagnosis, Differential | 4 | 2001 | 402 |
Why?
| Algorithms | 2 | 2009 | 226 |
Why?
| Chlamydia trachomatis | 3 | 2001 | 10 |
Why?
| Reproducibility of Results | 2 | 2007 | 391 |
Why?
| Prostate | 2 | 2007 | 55 |
Why?
| New York | 2 | 2005 | 422 |
Why?
| Incidence | 3 | 2004 | 336 |
Why?
| Herpesvirus 2, Human | 2 | 2000 | 7 |
Why?
| Unnecessary Procedures | 1 | 2010 | 13 |
Why?
| Urinalysis | 1 | 2010 | 17 |
Why?
| Risk Factors | 5 | 2003 | 555 |
Why?
| Combined Modality Therapy | 2 | 2006 | 219 |
Why?
| Female | 10 | 2000 | 1643 |
Why?
| Treatment Outcome | 3 | 2003 | 661 |
Why?
| Administration, Intravesical | 1 | 2009 | 17 |
Why?
| United States | 2 | 2004 | 604 |
Why?
| Ureaplasma urealyticum | 2 | 2003 | 5 |
Why?
| Aged, 80 and over | 5 | 2001 | 599 |
Why?
| Feasibility Studies | 2 | 2001 | 144 |
Why?
| Orgasm | 1 | 2007 | 4 |
Why?
| Simplexvirus | 2 | 2003 | 33 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 125 |
Why?
| Recurrence | 2 | 2006 | 261 |
Why?
| Biopsy | 2 | 2000 | 207 |
Why?
| Chemoprevention | 1 | 2006 | 12 |
Why?
| Sex Distribution | 2 | 2003 | 101 |
Why?
| Granuloma, Plasma Cell | 1 | 2006 | 8 |
Why?
| Practice Guidelines as Topic | 1 | 2009 | 174 |
Why?
| Nephrostomy, Percutaneous | 1 | 2006 | 7 |
Why?
| Neoplasm Recurrence, Local | 1 | 2009 | 118 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2009 | 176 |
Why?
| Drainage | 1 | 2006 | 50 |
Why?
| Carcinoma, Small Cell | 1 | 2006 | 20 |
Why?
| Doxorubicin | 1 | 2007 | 60 |
Why?
| Cyclophosphamide | 1 | 2007 | 82 |
Why?
| Treatment Failure | 1 | 2006 | 88 |
Why?
| Remission Induction | 1 | 2006 | 64 |
Why?
| Prednisone | 1 | 2007 | 80 |
Why?
| Herniorrhaphy | 1 | 2005 | 12 |
Why?
| Surgical Mesh | 1 | 2005 | 13 |
Why?
| Semen | 1 | 2005 | 15 |
Why?
| Enterococcus faecalis | 1 | 2005 | 11 |
Why?
| Retroperitoneal Space | 1 | 2004 | 11 |
Why?
| Blood | 1 | 2005 | 67 |
Why?
| Urethra | 2 | 2000 | 22 |
Why?
| Varicocele | 1 | 2004 | 13 |
Why?
| Pelvis | 1 | 2004 | 38 |
Why?
| Ureter | 1 | 2004 | 16 |
Why?
| History, 20th Century | 1 | 2005 | 111 |
Why?
| Deglutition Disorders | 1 | 2004 | 19 |
Why?
| Lymph Node Excision | 1 | 2004 | 30 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2002 | 121 |
Why?
| Urinary Bladder | 1 | 2004 | 37 |
Why?
| Hypophosphatemia | 1 | 2003 | 3 |
Why?
| Candidiasis | 1 | 2004 | 28 |
Why?
| Drug Therapy, Combination | 2 | 2000 | 189 |
Why?
| Prostatic Diseases | 1 | 2003 | 9 |
Why?
| Outpatient Clinics, Hospital | 1 | 2003 | 37 |
Why?
| Hepatectomy | 1 | 2003 | 24 |
Why?
| Age Distribution | 1 | 2004 | 127 |
Why?
| Tumor Markers, Biological | 1 | 2006 | 112 |
Why?
| Candida albicans | 1 | 2004 | 37 |
Why?
| Living Donors | 1 | 2003 | 27 |
Why?
| Dental Plaque | 1 | 2004 | 25 |
Why?
| Obesity | 1 | 2006 | 149 |
Why?
| Questionnaires | 1 | 2007 | 360 |
Why?
| Carcinoma, Lobular | 1 | 2002 | 16 |
Why?
| Bladder Exstrophy | 1 | 2001 | 2 |
Why?
| Urinary Bladder Calculi | 1 | 2001 | 5 |
Why?
| Sutures | 1 | 2001 | 18 |
Why?
| Survival Rate | 1 | 2004 | 250 |
Why?
| Chlamydia Infections | 1 | 2001 | 17 |
Why?
| Kidney Diseases | 1 | 2003 | 90 |
Why?
| Prognosis | 4 | 2001 | 388 |
Why?
| Scrotum | 1 | 2001 | 14 |
Why?
| Tomography, X-Ray Computed | 1 | 2006 | 321 |
Why?
| Buttocks | 1 | 2000 | 8 |
Why?
| Bordetella pertussis | 1 | 2000 | 9 |
Why?
| Kidney | 1 | 2004 | 223 |
Why?
| Liver Transplantation | 1 | 2003 | 54 |
Why?
| Child Day Care Centers | 1 | 2000 | 10 |
Why?
| Wounds, Penetrating | 1 | 2000 | 21 |
Why?
| Pertussis Vaccine | 1 | 2000 | 8 |
Why?
| Clinical Trials as Topic | 1 | 2004 | 251 |
Why?
| Chin | 1 | 2000 | 6 |
Why?
| Whooping Cough | 1 | 2000 | 14 |
Why?
| Hypesthesia | 1 | 2000 | 6 |
Why?
| Carcinoma, Renal Cell | 1 | 2001 | 48 |
Why?
| Herpes Simplex | 1 | 2000 | 31 |
Why?
| Chronic Disease | 1 | 2002 | 267 |
Why?
| Kidney Neoplasms | 1 | 2001 | 75 |
Why?
| Herpesvirus 1, Human | 1 | 2000 | 28 |
Why?
| Israel | 3 | 2000 | 20 |
Why?
| Carcinoma | 1 | 2000 | 109 |
Why?
| Antibodies, Viral | 1 | 2000 | 104 |
Why?
| Sensitivity and Specificity | 1 | 2000 | 427 |
Why?
| Demography | 2 | 2006 | 87 |
Why?
| Neoplasm Staging | 2 | 2006 | 125 |
Why?
| Breast Neoplasms | 1 | 2002 | 185 |
Why?
| Urine | 2 | 2003 | 35 |
Why?
| Adolescent | 4 | 2000 | 891 |
Why?
| Infant | 3 | 2000 | 464 |
Why?
| Prospective Studies | 2 | 2003 | 545 |
Why?
| Retrospective Studies | 2 | 2005 | 653 |
Why?
| Anti-Bacterial Agents | 2 | 2001 | 195 |
Why?
| Child, Preschool | 2 | 2000 | 554 |
Why?
| Wisconsin | 1 | 2006 | 6 |
Why?
| Time | 1 | 2006 | 41 |
Why?
| Intraoperative Complications | 1 | 2007 | 53 |
Why?
| Nutritional Status | 1 | 2006 | 27 |
Why?
| Organ Size | 1 | 2007 | 118 |
Why?
| Radiotherapy, Adjuvant | 1 | 2006 | 49 |
Why?
| Liver Diseases | 1 | 2006 | 56 |
Why?
| Immunophenotyping | 1 | 2006 | 66 |
Why?
| Erectile Dysfunction | 1 | 2005 | 11 |
Why?
| Liver Neoplasms | 1 | 2006 | 97 |
Why?
| Urinary Incontinence | 1 | 2005 | 28 |
Why?
| Pilot Projects | 1 | 2006 | 264 |
Why?
| Comorbidity | 1 | 2006 | 190 |
Why?
| Sexually Transmitted Diseases | 1 | 2005 | 18 |
Why?
| Rehabilitation Centers | 1 | 2004 | 4 |
Why?
| Dentures | 1 | 2004 | 5 |
Why?
| Child | 2 | 2000 | 749 |
Why?
| Lung Diseases | 1 | 2006 | 112 |
Why?
| Disease Progression | 1 | 2006 | 244 |
Why?
| Predictive Value of Tests | 1 | 2006 | 321 |
Why?
| Seroepidemiologic Studies | 1 | 2003 | 12 |
Why?
| Length of Stay | 1 | 2005 | 166 |
Why?
| Postoperative Period | 1 | 2003 | 63 |
Why?
| Phosphorus | 1 | 2003 | 29 |
Why?
| Trichomonas vaginalis | 1 | 2003 | 4 |
Why?
| Mycoplasma hominis | 1 | 2003 | 2 |
Why?
| Lung Neoplasms | 1 | 2006 | 159 |
Why?
| Nursing Homes | 1 | 2004 | 55 |
Why?
| Sexual Behavior | 1 | 2003 | 37 |
Why?
| Neisseria gonorrhoeae | 1 | 2003 | 11 |
Why?
| Immunohistochemistry | 1 | 2006 | 355 |
Why?
| Ethnic Groups | 1 | 2003 | 95 |
Why?
| Adenocarcinoma | 1 | 2006 | 167 |
Why?
| Safe Sex | 1 | 2001 | 5 |
Why?
| Stroke | 1 | 2004 | 59 |
Why?
| Infant, Newborn | 1 | 2006 | 389 |
Why?
| Prevalence | 1 | 2003 | 281 |
Why?
| Genital Diseases, Male | 1 | 2001 | 13 |
Why?
| Doxycycline | 1 | 2001 | 34 |
Why?
| Ploidies | 1 | 2001 | 20 |
Why?
| Angiogenesis Inducing Agents | 1 | 2001 | 14 |
Why?
| Cross-Sectional Studies | 1 | 2003 | 253 |
Why?
| Testicular Neoplasms | 1 | 2001 | 26 |
Why?
| Area Under Curve | 1 | 2001 | 47 |
Why?
| Ovarian Neoplasms | 1 | 2002 | 64 |
Why?
| Carrier State | 1 | 2000 | 20 |
Why?
| Genes, Tumor Suppressor | 1 | 2001 | 37 |
Why?
| DNA, Neoplasm | 1 | 2001 | 75 |
Why?
| Disease Susceptibility | 1 | 2000 | 61 |
Why?
| ROC Curve | 1 | 2001 | 80 |
Why?
| Uterine Neoplasms | 1 | 2002 | 52 |
Why?
| Chromosome Aberrations | 1 | 2001 | 45 |
Why?
| Goserelin | 1 | 2000 | 5 |
Why?
| Flutamide | 1 | 2000 | 10 |
Why?
| Immunoenzyme Techniques | 1 | 2000 | 125 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2000 | 30 |
Why?
| Syndrome | 1 | 2000 | 142 |
Why?
| Prostate-Specific Antigen | 1 | 2000 | 34 |
Why?
| Family | 1 | 2000 | 101 |
Why?
| Genetic Predisposition to Disease | 1 | 2001 | 131 |
Why?
| Flow Cytometry | 1 | 2001 | 216 |
Why?
| Polymerase Chain Reaction | 1 | 2000 | 279 |
Why?
| Animals | 1 | 2003 | 1031 |
Why?
|
|
Madeb's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
